Green Shield Canada

Ottawa has ordered more than 811 million rapid tests since the beginning of the pandemic with a price tag of about $5 billion. About 680 million of those went to provinces and territories.

Douglas Clark, executive director of the Patented Medicine Prices Review Board, announced today he will be leaving his post after almost a decade with the regulator.

A panel of paramedics, nurses, emergency room doctors, addictions workers, and advocates from the Ontario Nurses Association and the Ontario Health Coalition spoke at the Feb. 9 forum.

Two studies show bimekizumab is effective in treating this complex form of inflammatory arthritis.

A retail store in Camrose, Alta., was selling a medication that is not approved for sale in Canada to customers.

The statement was issued after new information on median overall survival rates from GlaxoSmithKline.

Korsuva (difelikefalin) is administered intravenously at the end of hemodialysis sessions.

Members of the committee held 36 meetings, heard from nearly 150 witnesses and reviewed more than 350 briefs on the medically assisted dying program.